of cytotoxic T and NK cells. Regarding its pro-tumorigenic role, mouse models of CRC, have demonstrated that pharmacological inhibition of extracellular GzmA reduces gut inflammation, prevents CRC ...

The World Health Organization (WHO) termed this disease "BPDCN" in 2008; previous names included blastic NK cell lymphoma and CD4+/CD56+ hematodermic neoplasm. Capillary leak syndrome (CLS ...